Ledger.Open graph →

SEC Form D · filed December 3, 2025

FibroBiologics, Inc

Offering

$4.0M

Sold

$4.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

HOUSTON, TX

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Pete O'Heeron · Houston, TXExec · Director Stacy Coen · Houston, TXDirector Victoria Niklas · Houston, TXDirector Robert Hoffman · Houston, TXDirector Jason D. Davis · Houston, TXExec Matthew Link · Houston, TXDirector Richard C. Cilento · Houston, TXDirector Stacy Coen · Houston, TXDirector Matthew Link · Houston, TXDirector Jason D. Davis · Houston, TXExec Robert Hoffman · Houston, TXDirector Victoria Niklas · Houston, TXDirector Pete O'Heeron · Houston, TXExec · Director Richard C. Cilento · Houston, TXDirector Larry M. Kellerman · Arlington, VADirector George P. Stamas · Arlington, VADirector Joseph M. Perta · Arlington, VADirector Paul J. Powers · Arlington, VAExec Jacob J. Worenklein · Arlington, VAExec · Director Timothy A. Krochuk · Boston, MADirector Gregory A. Fraser · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗